This report provides a comprehensive analysis of the global disposable medical device market, projecting steady growth through 2030. Driven by rising infection control concerns, an aging population, and the expansion of home healthcare, the market is seeing significant momentum in drug delivery devices, plastic-based materials, and Class II devices. While the Asia Pacific region is poised for the fastest expansion, the study also evaluates key competitive strategies and technological innovations among major industry players to support strategic decision-making.

Market Overview

The global disposable medical device market is projected to reach USD 144.85 billion by 2030, growing from USD 113.95 billion in 2025, at a CAGR of 4.9% during the forecast period.

Market Growth Drivers

• Infection Control: Rising concerns over hospital-acquired infections (HAIs) and increased regulatory emphasis on infection prevention.
• Surgical Demand: Increasing volume of surgical procedures.
• Economic Factors: The need for cost-effective, single-use solutions.
• Demographic & Health Trends: A growing elderly population and the rising prevalence of chronic diseases.
• Healthcare Shifts: Strong demand for home healthcare support.
• Technological & Regulatory Advancements: Advancements in manufacturing technology, materials, and regulatory focus on infection control and safety.

Market Segmentation Analysis

By Device Type

Drug Delivery Devices: This segment is projected to grow at the highest CAGR during the forecast period.

• Growth Drivers: Increasing prevalence of chronic diseases (e.g., diabetes, cancer, and autoimmune disorders) driving demand for disposable syringes, needles, and infusion sets for long-term therapy.
• Vaccination Trends: Global rise in vaccination programs, particularly post-pandemic, accelerating the adoption of single-use systems to reduce contamination risks.
• Home Care & Self-Administration: Growing preference for home-based care and self-administration of injectable drugs.
• Innovation: Technological advancements in prefilled syringes and auto-injectors for better convenience and compliance.
• Regulatory & Economic Factors: Regulatory push for infection prevention and the cost-effectiveness of disposables.

By Material

Plastic-Based Segment: This segment is projected to witness the fastest growth during the forecast period.

• Key Advantages: Cost-effectiveness, lightweight nature, high versatility, and ease of mass production.
• Commonly Used Materials: Polyethylene, polypropylene, and PVC used in syringes, catheters, and surgical instruments.
• Sustainability Trends: Advancements in biocompatible and recyclable plastics.

By Class of Device

Class II Segment: This segment is projected to grow at the highest CAGR during the forecast period.

• Clinical Application: Widespread use in essential medical procedures, infection prevention, and chronic disease management (e.g., surgical gloves, catheters, infusion sets, and diagnostic tools).
• Regulatory Advantage: These devices balance safety and regulatory requirements, allowing for faster time-to-market compared to Class III devices.
• Demand Drivers: Rising hospital admissions, outpatient procedures, and home healthcare setups, alongside post-pandemic infection control protocols.

By End User

Homecare Setting Segment: This segment is projected to grow at the highest CAGR during the forecast period.

• Preference Shifts: Increasing preference for home-based treatment among the elderly and patients with chronic illnesses.
• Economic Drivers: Rising costs of hospital care encouraging a shift toward affordable home care solutions.
• Technological Advancements: Development of compact, user-friendly, and safe devices such as insulin pens, wound dressings, and portable diagnostic tools.
• Patient Empowerment: Improved patient education and health management awareness allowing for independent condition management.

By Region

Asia Pacific: This region is projected to grow at the highest CAGR during the forecast period.

• Demographics & Urbanization: Rapid urbanization and an expanding middle-class population with increased healthcare access.
• Government Investment: Heavy investment in healthcare infrastructure and expanding insurance coverage in India, China, and Southeast Asia.
• Health Needs: Growing burden of chronic diseases, aging population, and rising awareness of infection prevention.
• Manufacturing Strength: A strong medical manufacturing base and cost-effective production capabilities serving as a hub for domestic and global supply.

Competitive Landscape

Primary Participant Breakdown (Supply-Side)

• By Company Type:
• Tier 1: 45%
• Tier 2: 20%
• Tier 3: 35%
• By Designation:
• C-level Executives: 35%
• Directors: 25%
• Others: 40%
• By Region:
• North America: 40%
• Europe: 25%
• Asia Pacific: 20%
• Latin America: 10%
• Middle East & Africa: 5%

Key Market Players

• Abbott (US)
• Alcon Inc. (Switzerland)
• Aspen Surgical Products, Inc. (US)
• Baxter (US)
• B Braun SE. (US)
• BD (US)
• Boston Scientific Corporation (US)
• Cardinal Health, Inc. (US)
• Coloplast (Denmark)
• Fresenius SE & Co. KGaA (Germany)
• Integra LifeSciences Holdings Corporation (US)
• ICU Medical, Inc. (US)
• Johnson & Johnson (US)
• Kirwan Surgical Products, LLC (US)
• Medline Industries, Inc. (US)
• Medtronic (Ireland)
• Merit Medical Systems (US)
• Nipro Corporation (Japan)
• Owens & Minor, Inc. (US)
• Paul Hartmann AG (Germany)
• Solventum (US)
• STERIS (US)
• Stryker Corporation (US)
• Teleflex Incorporated (US)
• Terumo Corporation (Japan)

Research Coverage & Strategic Insights

Scope of Analysis

This report estimates market size and future growth potential based on device type, device class, material, application, end user, and region. It includes a competitive analysis of key players, covering company profiles, product/service offerings, recent developments, and key market strategies.

Market Dynamics

• Drivers:
• Need for infection prevention and cross-contamination control.
• Growing volume of surgical and minimally invasive procedures.
• Technological innovations and sustainable alternatives.
• Regulatory support and guidelines.
• Restraints:
• High cumulative costs for bulk procurement of disposables.
• Advancements in sterilization and reprocessing technologies.
• Opportunities:
• Innovation in sustainable materials.
• Expansion in emerging markets and underserved regions.
• Challenges:
• Environmental concerns and regulatory scrutiny regarding medical waste.

Additional Market Intelligence

• Market Penetration: Extensive information on product portfolios offered by major global players.
• Product Enhancement/Innovation: Comprehensive details regarding product launches and anticipated market trends.
• Market Development: Thorough analysis of profitable markets categorized by device type, class, material, application, end user, and region.
• Market Diversification: Information on newly launched consumable products, expanding markets, current advancements, and investments.
• Competitive Assessment: Evaluation of market share, growth plans, product/service offerings, and capacities of major competitors.

Reasons to Buy the Report

• Revenue Approximation: Provides closest approximations of revenue for the overall market and its subsegments.
• Strategic Planning: Helps stakeholders understand the competitive landscape to position businesses and plan go-to-market strategies.
• Market Intelligence: Offers insights into the market pulse, including key drivers, restraints, challenges, and opportunities.

• 1 INTRODUCTION 44

  • 1.1 STUDY OBJECTIVES 44

  • 1.2 MARKET DEFINITION 45

    • 1.2.1 INCLUSIONS AND EXCLUSIONS 45

    • 1.2.2 MARKETS COVERED 46

    • 1.2.3 YEARS CONSIDERED 47

  • 1.3 CURRENCY CONSIDERED 47

  • 1.4 STAKEHOLDERS 48

• 2 RESEARCH METHODOLOGY 49

  • 2.1 RESEARCH APPROACH 49

    • 2.1.1 SECONDARY DATA 49

      • 2.1.1.1 Key data from secondary sources 50

    • 2.1.2 PRIMARY DATA 51

      • 2.1.2.1 Primary sources 51
      • 2.1.2.2 Key data from primary sources 52
      • 2.1.2.3 Breakdown of primary interviews 52

  • 2.2 MARKET SIZE ESTIMATION 53

  • 2.3 GROWTH FORECAST 57

  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 59

  • 2.5 KEY INDUSTRY INSIGHTS 60

  • 2.6 RESEARCH LIMITATIONS 60

    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS 61

  • 2.7 RISK ASSESSMENT 61

  • 2.8 RESEARCH ASSUMPTIONS 61

• 3 EXECUTIVE SUMMARY 62

• 4 PREMIUM INSIGHTS 67

  • 4.1 DISPOSABLE MEDICAL DEVICE MARKET OVERVIEW 67

  • 4.2 ASIA PACIFIC DISPOSABLE MEDICAL DEVICE MARKET, BY APPLICATION AND COUNTRY 68

  • 4.3 DISPOSABLE MEDICAL DEVICE MARKET: DEVELOPED VS. EMERGING ECONOMIES 69

  • 4.4 DISPOSABLE MEDICAL DEVICE MARKET, BY COUNTRY 70

  • 4.5 DISPOSABLE MEDICAL DEVICE MARKET: REGIONAL MIX 71

• 5 MARKET OVERVIEW 72

  • 5.1 INTRODUCTION 72

  • 5.2 MARKET DYNAMICS 72

    • 5.2.1 DRIVERS 73

      • 5.2.1.1 Infection prevention & cross-contamination control 73
      • 5.2.1.2 Growing surgical volumes and minimally invasive procedures 74
      • 5.2.1.3 Technological innovations and sustainable alternatives 75
      • 5.2.1.4 Regulatory support and guidelines 76

    • 5.2.2 RESTRAINTS 77

      • 5.2.2.1 High cumulative costs for large-volume users 77
      • 5.2.2.2 Advancements in sterilization methods and reprocessing technologies 77

    • 5.2.3 OPPORTUNITIES 78

      • 5.2.3.1 Innovation in sustainable materials 78
      • 5.2.3.2 Expansion in emerging markets and underserved regions 79

    • 5.2.4 CHALLENGES 80

      • 5.2.4.1 Environmental concerns and regulatory scrutiny of medical waste 80

  • 5.3 INDUSTRY TRENDS 81

    • 5.3.1 ADVANCEMENTS IN MATERIAL SCIENCE AND SUSTAINABLE DESIGN 81

    • 5.3.2 GROWING INTEREST OF PRIVATE EQUITY FIRMS IN DISPOSABLE MEDICAL DEVICE MARKET 81

    • 5.3.3 OUTSOURCING OF DISPOSABLE MEDICAL DEVICE SERVICES 82

  • 5.4 TECHNOLOGY ANALYSIS 83

    • 5.4.1 KEY TECHNOLOGIES 83

      • 5.4.1.1 Biodegradable/Biopolymer materials 83
      • 5.4.1.2 IoMT-enabled smart disposables 83

    • 5.4.2 ADJACENT TECHNOLOGIES 84

      • 5.4.2.1 3D printing (additive manufacturing) 84
      • 5.4.2.2 Wearable sensors 84

    • 5.4.3 COMPLEMENTARY TECHNOLOGIES 85

      • 5.4.3.1 Sterilization technologies 85

  • 5.5 PORTER’S FIVE FORCES ANALYSIS 86

    • 5.5.1 THREAT OF NEW ENTRANTS 87

      • 5.5.1.1 Barriers to entry 87
      • 5.5.1.2 Brand loyalty and trust 87
      • 5.5.1.3 Demand for compact, cost-effective, and non-invasive devices 87
      • 5.5.1.4 Poor financing environment 87

    • 5.5.2 THREAT OF SUBSTITUTES 88

      • 5.5.2.1 Sustainability & environmental concerns 88
      • 5.5.2.2 Growth of reusable and hybrid devices 88
      • 5.5.2.3 Availability of alternatives 88

    • 5.5.3 BARGAINING POWER OF SUPPLIERS 88

      • 5.5.3.1 Raw material dependency and volume demand 88
      • 5.5.3.2 Role of contract manufacturing organizations (CMOs) 88
      • 5.5.3.3 Regulatory & compliance constraints 88
      • 5.5.3.4 Innovation vs. commoditization 89

    • 5.5.4 BARGAINING POWER OF BUYERS 89

      • 5.5.4.1 Price sensitivity and bulk procurement 89
      • 5.5.4.2 Regulatory and quality expectations 89
      • 5.5.4.3 Low switching cost 89
      • 5.5.4.4 Growth of centralized procurement models 89

    • 5.5.5 INTENSITY OF COMPETITIVE RIVALRY 89

      • 5.5.5.1 Standardized product offerings 89
      • 5.5.5.2 Overlapping target customers 89
      • 5.5.5.3 Cost efficiency and scale as differentiators 90
      • 5.5.5.4 Low exit barriers 90

  • 5.6 REGULATORY LANDSCAPE 90

    • 5.6.1 REGULATORY FRAMEWORK 90

      • 5.6.1.1 North America 90
        • 5.6.1.1.1 US 90
        • 5.6.1.1.2 Canada 91
      • 5.6.1.2 Europe 92
      • 5.6.1.3 Asia Pacific 92
        • 5.6.1.3.1 Japan 92
        • 5.6.1.3.2 China 93
        • 5.6.1.3.3 India 94

    • 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND

  • 5.7 PRICING ANALYSIS 97

    • 5.7.1 AVERAGE SELLING PRICE RANGE FOR DISPOSABLE MEDICAL DEVICES

    • 5.7.2 AVERAGE SELLING PRICE RANGE, BY REGION, 2022-2024 98

  • 5.8 VALUE CHAIN ANALYSIS 98

  • 5.9 KEY CONFERENCES AND EVENTS IN 2025-2026 100

  • 5.10 PATENT ANALYSIS 101

    • 5.10.1 INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS, AND JURISDICTIONS FOR DISPOSABLE MEDICAL DEVICE MARKET 101

    • 5.10.2 LIST OF MAJOR PATENTS, JANUARY 2022-JUNE 2025 103

  • 5.11 SUPPLY CHAIN ANALYSIS 104

  • 5.12 ECOSYSTEM ANALYSIS 105

  • 5.13 TRADE ANALYSIS 106

    • 5.13.1 IMPORT DATA FOR HS CODE 9018, 2020-2024 107

    • 5.13.2 EXPORT DATA FOR HS CODE 9018, 2020-2024 107

  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 108

    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 108

    • 5.14.2 BUYING CRITERIA 109

  • 5.15 ADJACENT MARKETS FOR DISPOSABLE MEDICAL DEVICES 110

  • 5.16 UNMET NEEDS/END USER EXPECTATIONS IN DISPOSABLE MEDICAL DEVICE MARKET 110

  • 5.17 IMPACT OF GEN AI IN DISPOSABLE MEDICAL DEVICE MARKET 111

  • 5.18 INVESTMENT AND FUNDING SCENARIO 112

  • 5.19 IMPACT OF 2025 US TARIFFS 112

    • 5.19.1 INTRODUCTION 112

    • 5.19.2 KEY TARIFF RATES 113

    • 5.19.3 PRICE IMPACT ANALYSIS 114

    • 5.19.4 IMPACT ON COUNTRY/REGION 114

      • 5.19.4.1 US 114
      • 5.19.4.2 Europe 115
      • 5.19.4.3 Asia Pacific 115

    • 5.19.5 IMPACT ON END-USE INDUSTRIES 115

      • 5.19.5.1 Hospitals and clinics 115
      • 5.19.5.2 Ambulatory surgical centers 115
      • 5.19.5.3 Home care settings 116

• 6 DISPOSABLE MEDICAL DEVICE MARKET, BY DEVICE TYPE 117

  • 6.1 INTRODUCTION 118

  • 6.2 DRUG DELIVERY DEVICES 119

    • 6.2.1 SYRINGES 123

      • 6.2.1.1 Growing demand for safe injection practices, mass immunization programs, and rising chronic conditions to drive market 123

    • 6.2.2 NEEDLES 125

      • 6.2.2.1 Increasing focus on injection safety, rising chronic disease burden, and hospital-acquired infection control to drive market 125

    • 6.2.3 IV CATHETERS 127

      • 6.2.3.1 Increased procedural volume, safety mandates, and infection prevention to drive market 127

    • 6.2.4 INFUSION SETS 129

      • 6.2.4.1 Growth in chronic disease management, inpatient therapies, and home care fuels infusion to drive demand 129

    • 6.2.5 PREFILLED FLUSH SYRINGES 131

      • 6.2.5.1 Focus on infection prevention, workflow efficiency, and catheter maintenance to propel adoption of disposable prefilled flush syringes 131

    • 6.2.6 DISPOSABLE NEBULIZER KITS 133

      • 6.2.6.1 Rising respiratory disease burden, infection control mandates, and outpatient therapy to fuel demand for disposable nebulizer kits 133

    • 6.2.7 NASAL SPRAY DEVICES 135

      • 6.2.7.1 Convenience, dose accuracy, and expanding intranasal drug delivery applications to fuel demand for disposable nasal spray devices 135

    • 6.2.8 INHALERS 137

      • 6.2.8.1 Rise in respiratory disease prevalence and demand for infection-free, portable treatment to drive growth 137

  • 6.3 SURGICAL & PROCEDURAL INSTRUMENTS 139

    • 6.3.1 STAPLERS 143

      • 6.3.1.1 Rising adoption in minimally invasive and outpatient surgeries to drive market 143

    • 6.3.2 FORCEPS & SCALPELS 145

      • 6.3.2.1 Enhanced infection control and growing demand in emergency settings to fuel growth 145

    • 6.3.3 SUCTION TUBES 147

      • 6.3.3.1 Rising focus on infection control and operative efficiency to drive demand for disposable suction tubes 147

    • 6.3.4 CURETTES 149

      • 6.3.4.1 Growing preference for single-use instruments in OB/GYN, ENT, and dermatological procedures to drive market 149

    • 6.3.5 TROCARS & CANNULAS 151

      • 6.3.5.1 Increasing laparoscopic procedures and infection control mandates to fuel demand for disposable trocars & cannulas 151

    • 6.3.6 ELECTROCAUTERY PENCILS 153

      • 6.3.6.1 Rise in surgical volume and stricter infection control standards to bolster demand for disposable electrocautery pencils 153

    • 6.3.7 HEMOSTATIC CLIPS 155

      • 6.3.7.1 Increasing use of disposable hemostatic clips in minimally invasive procedures to prevent bleeding 155

    • 6.3.8 GRASPERS 157

      • 6.3.8.1 Growing demand for cost-effective and infection-safe instruments in laparoscopic and general surgeries to drive market 157

  • 6.4 CATHETERS & TUBES 159

    • 6.4.1 URINARY CATHETERS 162

      • 6.4.1.1 Increasing urinary incontinence cases and focus on infection control to drive demand 162

    • 6.4.2 GLOBAL VOLUME ANALYSIS OF URINARY CATHETERS

    • 6.4.3 CENTRAL VENOUS CATHETERS 164

      • 6.4.3.1 Increasing adoption in critical care & infection-control driven protocols to fuel market 164

    • 6.4.4 GLOBAL VOLUME ANALYSIS OF CENTRAL VENOUS CATHETERS

    • 6.4.5 NASOGASTRIC TUBES 166

      • 6.4.5.1 Clinical versatility, infection control protocols, and demand from critical care units to drive market 166

    • 6.4.6 FEEDING TUBES 168

      • 6.4.6.1 Rising geriatric population, chronic conditions, and shift toward home nutrition support to fuel market 168

    • 6.4.7 ENDOTRACHEAL TUBES 170

      • 6.4.7.1 Rising critical care procedures and infection prevention measures to drive demand 170

  • 6.5 PERSONAL PROTECTIVE EQUIPMENT (PPE) 172

    • 6.5.1 GLOVES 176

      • 6.5.1.1 Rising infection control measures, surgical volumes, and hygiene protocols to drive market expansion 176

    • 6.5.2 FACE MASKS 178

      • 6.5.2.1 Rising emphasis on infection control, airborne disease prevention, and occupational safety to fuel market growth 178

    • 6.5.3 GOWNS & CAPS 180

      • 6.5.3.1 Stringent infection control guidelines and pandemic-driven protocols to boost adoption of single-use protective apparel 180

  • 6.6 DIAGNOSTIC & TESTING DEVICES 182

    • 6.6.1 LATERAL FLOW ASSAYS 185

      • 6.6.1.1 Rise in point-of-care diagnostics and infectious disease surveillance to drive market expansion 185

    • 6.6.2 GLOBAL VOLUME ANALYSIS OF LATERAL FLOW ASSAYS

    • 6.6.3 BLOOD GLUCOSE STRIPS 187

      • 6.6.3.1 Rising diabetes burden and shift toward home-based monitoring to drive demand 187

    • 6.6.4 GLOBAL VOLUME ANALYSIS OF BLOOD GLUCOSE STRIPS

    • 6.6.5 SWABS 189

      • 6.6.5.1 Rising demand from diagnostic testing, infection surveillance, and point-of-care settings to drive growth 189

    • 6.6.6 SPECIMEN CONTAINERS 191

      • 6.6.6.1 Rising emphasis on diagnostic accuracy, infection control, and regulatory compliance to drive growth 191

    • 6.6.7 DISPOSABLE THERMOMETERS 193

      • 6.6.7.1 Infection prevention, cost-effectiveness, and point-of-care efficiency to drive growth 193

    • 6.6.8 ECG ELECTRODES 195

      • 6.6.8.1 Rising cardiac monitoring needs & infection prevention measures to drive demand 195

  • 6.7 RESPIRATORY & ANESTHESIA DEVICES 197

    • 6.7.1 OXYGEN MASKS 200

      • 6.7.1.1 Rising incidence of respiratory disorders & emergency care utilization to boost market 200

    • 6.7.2 NASAL CANNULAS 202

      • 6.7.2.1 Growing respiratory patient pool and home oxygen therapy to drive demand 202

    • 6.7.3 HEAT MOISTURE EXCHANGERS 204

      • 6.7.3.1 Critical role in airway management and ICU ventilation to drive market 204

    • 6.7.4 ANESTHESIA CIRCUITS 206

      • 6.7.4.1 Rising focus on cross-contamination prevention and or efficiency to drive market 206

    • 6.7.5 DISPOSABLE LARYNGOSCOPE BLADES 208

      • 6.7.5.1 Rising focus on cross-contamination control & emergency preparedness to drive demand 208

  • 6.8 UROLOGY & GYNECOLOGY DEVICES 210

    • 6.8.1 DISPOSABLE VAGINAL SPECULUMS 213

      • 6.8.1.1 Rising gynecological screening, infection control, and patient-centric care to drive market 213

    • 6.8.2 SINGLE-USE HYSTEROSCOPY CATHETERS 215

      • 6.8.2.1 Rising preference for minimally invasive gynecological procedures & infection control to propel demand 215

    • 6.8.3 URETHRAL DILATORS 217

      • 6.8.3.1 Rising preference for minimally invasive gynecological procedures & infection control to propel demand 217

  • 6.9 OPHTHALMIC & ENT DEVICES 218

    • 6.9.1 OPHTHALMIC SURGICAL BLADES 221

      • 6.9.1.1 Precision in microsurgery and focus on sterility drive market 221

    • 6.9.2 ENT SUCTION TIPS 223

      • 6.9.2.1 Rising surgical volumes, infection control protocols, and pediatric ENT procedures to propel market 223

    • 6.9.3 DISPOSABLE OTOSCOPE SPECULA 225

      • 6.9.3.1 Rising infection prevention measures and pediatric applications to drive market 225

  • 6.10 OTHER DEVICES 227

• 7 DISPOSABLE MEDICAL DEVICE MARKET, BY DEVICE CLASS 229

  • 7.1 INTRODUCTION 230

  • 7.2 CLASS I 230

    • 7.2.1 POSSESS MINIMUM POTENTIAL TO HARM USERS 230

  • 7.3 CLASS II 232

    • 7.3.1 REQUIRE REGULATORY CONTROLS TO ENSURE SAFETY AND EFFICACY 232

  • 7.4 CLASS III 234

    • 7.4.1 ESSENTIAL IN PREVENTING HEALTH IMPAIRMENT OR POTENTIAL UNREASONABLE RISK OF ILLNESS OR INJURY 234

• 8 DISPOSABLE MEDICAL DEVICE MARKET, BY MATERIAL 236

  • 8.1 INTRODUCTION 237

  • 8.2 PLASTIC BASED 237

    • 8.2.1 SHIFT TOWARD PLASTICS FOR AFFORDABILITY, DESIGN FLEXIBILITY, AND INFECTION CONTROL TO DRIVE DEMAND 237

  • 8.3 METAL BASED 240

    • 8.3.1 DEMAND FOR PRECISION, STRENGTH, AND SINGLE-USE COMPLIANCE TO DRIVE GROWTH 240

  • 8.4 RUBBER BASED 242

    • 8.4.1 WIDESPREAD USE IN SEALING, DAMPING, AND BIOCOMPATIBLE APPLICATIONS TO DRIVE DEMAND 242

  • 8.5 OTHER MATERIALS 244

• 9 DISPOSABLE MEDICAL DEVICE MARKET, BY END USER 246

  • 9.1 INTRODUCTION 247

  • 9.2 HOSPITALS 247

    • 9.2.1 PUBLIC HOSPITALS 250

    • 9.2.2 PRIVATE HOSPITALS 252

  • 9.3 AMBULATORY SURGICAL CENTERS 254

    • 9.3.1 GROWING PREFERENCE FOR DISPOSABLE MEDICAL DEVICES IN AMBULATORY SETTINGS DRIVEN BY INFECTION CONTROL, OPERATIONAL EFFICIENCY, AND REGULATORY COMPLIANCE 254

  • 9.4 HOMECARE SETTING 256

    • 9.4.1 RISING DEMAND FOR SELF-ADMINISTERED AND REMOTE CARE TO FUEL GROWTH 256

  • 9.5 OTHER END USERS 258

• 10 DISPOSABLE MEDICAL DEVICE MARKET, BY APPLICATION 260

  • 10.1 INTRODUCTION 261

  • 10.2 GENERAL SURGERY 262

    • 10.2.1 INCREASING USE OF DISPOSABLE INSTRUMENTS IN OPERATING ROOMS TO REDUCE INFECTIONS AND IMPROVE EFFICIENCY 262

  • 10.3 RESPIRATORY 264

    • 10.3.1 INCREASING RESPIRATORY DISEASE BURDEN, INFECTION CONTROL MEASURES, AND AT-HOME VENTILATION TO FUEL DEMAND 264

  • 10.4 UROLOGY 266

    • 10.4.1 RISING GERIATRIC POPULATION, INFECTION PREVENTION PROTOCOLS, AND AT-HOME CARE MODELS TO DRIVE DEMAND 266

  • 10.5 GYNECOLOGY 268

    • 10.5.1 GROWING EMPHASIS ON INFECTION CONTROL, AMBULATORY CARE, AND TECHNOLOGICAL SIMPLICITY TO DRIVE DEMAND 268

  • 10.6 WOUND CARE 270

    • 10.6.1 RISING SURGICAL PROCEDURES AND DIABETIC ULCERS TO DRIVE DEMAND 270

  • 10.7 DIAGNOSTIC & MONITORING 272

    • 10.7.1 RISING DEMAND FOR CHRONIC DISEASE MANAGEMENT AND HOME-BASED MONITORING TO DRIVE MARKET 272

  • 10.8 CARDIOVASCULAR 274

    • 10.8.1 RISING CARDIOVASCULAR DISEASE BURDEN AND TECHNOLOGICAL INNOVATIONS TO DRIVE DEMAND 274

  • 10.9 INFECTION CONTROL 276

    • 10.9.1 EMPHASIS ON HAIS PREVENTION, REGULATORY PRESSURE, AND PANDEMIC PREPAREDNESS TO DRIVE GROWTH 276

  • 10.10 ICU/EMERGENCY 278

    • 10.10.1 RISING ACUTE CARE DEMAND & INFECTION PREVENTION PROTOCOLS TO ACCELERATE DISPOSABLE DEVICE USE IN CRITICAL SETTINGS 278

  • 10.11 OTHER APPLICATIONS 280

• 11 DISPOSABLE MEDICAL DEVICE MARKET, BY REGION 282

  • 11.1 INTRODUCTION 283

    • 11.1.1 GLOBAL VOLUME ANALYSIS OF CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES, 2023-2030 (THOUSAND UNITS) 284

  • 11.2 NORTH AMERICA 285

    • 11.2.1 MACROECONOMIC OUTLOOK 285

    • 11.2.2 NORTH AMERICA: VOLUME ANALYSIS OF CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES, 2023-2030 (THOUSAND UNITS) 287

    • 11.2.3 US 293

      • 11.2.3.1 Growth fueled by regulatory push, rising chronic diseases, and infection control mandates 293

    • 11.2.4 CANADA 300

      • 11.2.4.1 Stringent infection control regulations and chronic disease burden to propel growth 300

  • 11.3 ASIA PACIFIC 307

    • 11.3.1 MACROECONOMIC OUTLOOK 308

    • 11.3.2 ASIA PACIFIC: VOLUME ANALYSIS OF CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES, 2023-2030 (THOUSAND UNITS) 310

    • 11.3.3 JAPAN 317

      • 11.3.3.1 Aging population, infection control norms, and technological innovation to fuel growth 317

    • 11.3.4 CHINA 324

      • 11.3.4.1 Aging population, regulatory push, and local manufacturing to fuel growth 324

    • 11.3.5 INDIA 331

      • 11.3.5.1 Rising focus on infection control, government schemes, and domestic manufacturing to drive growth 331

    • 11.3.6 AUSTRALIA 338

      • 11.3.6.1 Growing emphasis on infection control, aging population, and local manufacturing push to drive growth 338

    • 11.3.7 SOUTH KOREA 345

      • 11.3.7.1 Regulatory streamlining, digital healthcare infrastructure, and local production to drive growth 345

    • 11.3.8 REST OF ASIA PACIFIC 352

  • 11.4 EUROPE 359

    • 11.4.1 MACROECONOMIC OUTLOOK 359

    • 11.4.2 EUROPE: VOLUME ANALYSIS OF CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES, 2023-2030 (THOUSAND UNITS) 360

    • 11.4.3 GERMANY 367

      • 11.4.3.1 Strong regulatory standards, aging population, and digital health integration to drive adoption 367

    • 11.4.4 UK 374

      • 11.4.4.1 Stringent infection control regulations, NHS procurement, and sustainability initiatives to drive growth 374

    • 11.4.5 FRANCE 381

      • 11.4.5.1 Regulatory alignment, rising infection control standards, and shift toward ambulatory care to drive market 381

    • 11.4.6 SPAIN 388

      • 11.4.6.1 Rising hospital admissions, infection control regulations, and public-private healthcare investment to fuel growth 388

    • 11.4.7 ITALY 395

      • 11.4.7.1 Aging population, healthcare reforms, and infection prevention measures to accelerate market growth 395

    • 11.4.8 REST OF EUROPE 402

  • 11.5 LATIN AMERICA 409

    • 11.5.1 MACROECONOMIC OUTLOOK 409

    • 11.5.2 LATIN AMERICA: VOLUME ANALYSIS OF CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES, 2023-2030 (THOUSAND UNITS) 410

    • 11.5.3 BRAZIL 417

      • 11.5.3.1 Public health expansion, domestic manufacturing push, and infection control measures to drive growth 417

    • 11.5.4 MEXICO 424

      • 11.5.4.1 Regulatory reform, healthcare expansion, and public health investments to drive market growth 424

    • 11.5.5 REST OF LATIN AMERICA 431

  • 11.6 MIDDLE EAST & AFRICA 438

    • 11.6.1 MACROECONOMIC OUTLOOK 438

    • 11.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES, 2023-2030 (THOUSAND UNITS) 439

    • 11.6.3 GCC COUNTRIES 446

      • 11.6.3.1 Kingdom of Saudi Arabia (KSA) 453
        • 11.6.3.1.1 Healthcare system transformation and regulatory focus to drive demand for disposable medical device types 453
      • 11.6.3.2 UAE 460
        • 11.6.3.2.1 Growing ICU procedures, chronic disease therapy needs, and infection control mandates to drive disposable CVC adoption 460
      • 11.6.3.3 Rest of GCC Countries 467

    • 11.6.4 REST OF MIDDLE EAST & AFRICA 473

• 12 COMPETITIVE LANDSCAPE 481

  • 12.1 OVERVIEW 481

    • 12.1.1 KEY STRATEGIES ADOPTED BY PLAYERS IN DISPOSABLE MEDICAL DEVICE MARKET 481

  • 12.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 483

  • 12.3 MARKET SHARE ANALYSIS 484

    • 12.3.1 DISPOSABLE MEDICAL DEVICE MARKET SHARE, BY KEY PLAYERS

    • 12.3.2 DISPOSABLE MEDICAL DEVICE MARKET SHARE, BY KEY PLAYERS, 2024 (US) 486

  • 12.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 486

    • 12.4.1 STARS 487

    • 12.4.2 EMERGING LEADERS 487

    • 12.4.3 PERVASIVE PLAYERS 487

    • 12.4.4 PARTICIPANTS 487

    • 12.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 489

      • 12.4.5.1 Company footprint 489
      • 12.4.5.2 Regional footprint 490
      • 12.4.5.3 Device type footprint 491
      • 12.4.5.4 Material footprint 493
      • 12.4.5.5 Device class footprint 494
      • 12.4.5.6 Application footprint 495

  • 12.5 COMPANY EVALUATION MATRIX, STARTUPS/ SMES, 2024 496

    • 12.5.1 PROGRESSIVE COMPANIES 496

    • 12.5.2 RESPONSIVE COMPANIES 496

    • 12.5.3 DYNAMIC COMPANIES 497

    • 12.5.4 STARTING BLOCKS 497

    • 12.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 498

      • 12.5.5.1 List of key startups/SMEs 498
      • 12.5.5.2 Competitive benchmarking of key startups/SMEs 498

  • 12.6 COMPANY VALUATION AND FINANCIAL METRICS 499

    • 12.6.1 FINANCIAL METRICS 499

    • 12.6.2 COMPANY VALUATION 499

  • 12.7 BRAND/PRODUCT COMPARATIVE ANALYSIS 500

  • 12.8 R&D ASSESSMENT OF KEY PLAYERS 501

  • 12.9 COMPETITIVE SCENARIO 501

    • 12.9.1 PRODUCT LAUNCHES AND APPROVALS 501

    • 12.9.2 DEALS 502

    • 12.9.3 OTHER DEVELOPMENTS 503

• 13 COMPANY PROFILES 504

  • 13.1 KEY PLAYERS 504

    • 13.1.1 JOHNSON & JOHNSON 504

      • 13.1.1.1 Business overview 504
      • 13.1.1.2 Products offered 505
      • 13.1.1.3 Recent developments 506
        • 13.1.1.3.1 Product approvals 506
      • 13.1.1.4 MnM view 507
        • 13.1.1.4.1 Right to win 507
        • 13.1.1.4.2 Strategic choices 507
        • 13.1.1.4.3 Weaknesses and competitive threats 507

    • 13.1.2 BD 508

      • 13.1.2.1 Business overview 508
      • 13.1.2.2 Products offered 509
      • 13.1.2.3 Recent developments 512
        • 13.1.2.3.1 Product launches 512
        • 13.1.2.3.2 Deals 512
        • 13.1.2.3.3 Expansions 513
      • 13.1.2.4 MnM view 513
        • 13.1.2.4.1 Right to win 513
        • 13.1.2.4.2 Strategic choices 514
        • 13.1.2.4.3 Weaknesses and competitive threats 514

    • 13.1.3 CARDINAL HEALTH 515

      • 13.1.3.1 Business overview 515
      • 13.1.3.2 Products offered 516
      • 13.1.3.3 Recent developments 519
        • 13.1.3.3.1 Deals 519
        • 13.1.3.3.2 Expansions 519
      • 13.1.3.4 MnM view 520
        • 13.1.3.4.1 Right to win 520
        • 13.1.3.4.2 Strategic choices 520
        • 13.1.3.4.3 Weaknesses and competitive threats 520

    • 13.1.4 MEDTRONIC 521

      • 13.1.4.1 Business overview 521
      • 13.1.4.2 Products offered 522
      • 13.1.4.3 Recent developments 524
        • 13.1.4.3.1 Product launches 524
        • 13.1.4.3.2 Deals 524
      • 13.1.4.4 MnM view 525
        • 13.1.4.4.1 Right to win 525
        • 13.1.4.4.2 Strategic choices 525
        • 13.1.4.4.3 Weaknesses and competitive threats 525

    • 13.1.5 ABBOTT 526

      • 13.1.5.1 Business overview 526
      • 13.1.5.2 Products offered 527
      • 13.1.5.3 Recent developments 528
        • 13.1.5.3.1 Deals 528
      • 13.1.5.4 MnM view 528
        • 13.1.5.4.1 Right to win 528
        • 13.1.5.4.2 Strategic choices 528
        • 13.1.5.4.3 Weaknesses and competitive threats 528

    • 13.1.6 SOLVENTUM 529

      • 13.1.6.1 Business overview 529
      • 13.1.6.2 Products offered 530
      • 13.1.6.3 Recent developments 531
        • 13.1.6.3.1 Deals 531
        • 13.1.6.3.2 Other developments 531

    • 13.1.7 BOSTON SCIENTIFIC CORPORATION 532

      • 13.1.7.1 Business overview 532
      • 13.1.7.2 Products offered 533
      • 13.1.7.3 Recent developments 535
        • 13.1.7.3.1 Product approvals 535

    • 13.1.8 BAXTER 536

      • 13.1.8.1 Business overview 536
      • 13.1.8.2 Products offered 537
      • 13.1.8.3 Recent developments 540
        • 13.1.8.3.1 Product approvals 540
        • 13.1.8.3.2 Other developments 540

    • 13.1.9 TERUMO CORPORATION 541

      • 13.1.9.1 Business overview 541
      • 13.1.9.2 Products offered 542
      • 13.1.9.3 Recent developments 543
        • 13.1.9.3.1 Product launches 543
        • 13.1.9.3.2 Expansions 544

    • 13.1.10 NIPRO CORPORATION 545

      • 13.1.10.1 Business overview 545
      • 13.1.10.2 Products offered 546
      • 13.1.10.3 Recent developments 547
        • 13.1.10.3.1 Expansions 547

    • 13.1.11 TELEFLEX INCORPORATED 548

      • 13.1.11.1 Business overview 548
      • 13.1.11.2 Products offered 549
      • 13.1.11.3 Recent developments 550
        • 13.1.11.3.1 Product launches 550
        • 13.1.11.3.2 Deals 551

    • 13.1.12 STRYKER 552

      • 13.1.12.1 Business overview 552
      • 13.1.12.2 Products offered 553
      • 13.1.12.3 Recent developments 554
        • 13.1.12.3.1 Product approvals 554

    • 13.1.13 FRESENIUS KABI AG 555

      • 13.1.13.1 Business overview 555
      • 13.1.13.2 Products offered 556
      • 13.1.13.3 Recent developments 557
        • 13.1.13.3.1 Product approvals 557
        • 13.1.13.3.2 Deals 558
        • 13.1.13.3.3 Other developments 558

    • 13.1.14 MEDLINE INDUSTRIES, INC 559

      • 13.1.14.1 Business overview 559
      • 13.1.14.2 Products offered 559
      • 13.1.14.3 Recent developments 561
        • 13.1.14.3.1 Deals 561

    • 13.1.15 MERIT MEDICAL SYSTEMS 562

      • 13.1.15.1 Business overview 562
      • 13.1.15.2 Products offered 563
      • 13.1.15.3 Recent developments 565
        • 13.1.15.3.1 Deals 565

    • 13.1.16 B. BRAUN SE 566

      • 13.1.16.1 Business overview 566
      • 13.1.16.2 Products offered 567
      • 13.1.16.3 Recent developments 569
        • 13.1.16.3.1 Product launches and approvals 569
        • 13.1.16.3.2 Deals 570
        • 13.1.16.3.3 Other developments 571

    • 13.1.17 ALCON INC 572

      • 13.1.17.1 Business overview 572
      • 13.1.17.2 Products offered 573
      • 13.1.17.3 Recent developments 574
        • 13.1.17.3.1 Deals 574

  • 13.2 OTHER PLAYERS 575

    • 13.2.1 ICU MEDICAL, INC 575

    • 13.2.2 STERIS 576

    • 13.2.3 INTEGRA LIFESCIENCES CORPORATION 577

    • 13.2.4 COLOPLAST CORP 578

    • 13.2.5 PAUL HARTMANN AG 579

    • 13.2.6 OWENS & MINOR 580

    • 13.2.7 KIRWAN SURGICAL PRODUCTS, LLC 581

    • 13.2.8 ASPEN SURGICAL PRODUCTS, INC 582

• 14 APPENDIX 585

  • 14.1 DISCUSSION GUIDE 585

  • 14.2 CUSTOMIZATION OPTIONS 594

    • 14.2.1 DEVICE TYPE ANALYSIS 594

    • 14.2.2 GEOGRAPHIC ANALYSIS 594

    • 14.2.3 COMPANY INFORMATION 594

    • 14.2.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 594

    • 14.2.5 COUNTRY-LEVEL VOLUME ANALYSIS BY CATHETERS & TUBES AND DIAGNOSTIC & TESTING DEVICES 594

    • 14.2.6 BY DEVICE TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS) 594

    • 14.2.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 594

  • 14.3 RELATED REPORTS 594

  • 14.4 AUTHOR DETAILS 595

• 2024 (GLOBAL) 484